I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| classical monocyte | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of CD300LB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 99% | 171.39 | 575 / 578 | 51% | 1.11 | 592 / 1155 |
| breast | 73% | 73.09 | 336 / 459 | 48% | 1.32 | 536 / 1118 |
| kidney | 43% | 23.62 | 38 / 89 | 71% | 2.06 | 641 / 901 |
| intestine | 81% | 34.67 | 780 / 966 | 27% | 0.55 | 143 / 527 |
| bladder | 71% | 59.05 | 15 / 21 | 29% | 0.57 | 145 / 504 |
| spleen | 100% | 237.73 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 1342.62 | 925 / 929 | 0% | 0 | 0 / 0 |
| adipose | 94% | 152.24 | 1132 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 68% | 29.72 | 167 / 245 | 25% | 0.43 | 125 / 502 |
| adrenal gland | 77% | 28.94 | 198 / 258 | 15% | 0.34 | 34 / 230 |
| pancreas | 27% | 9.51 | 88 / 328 | 61% | 1.61 | 109 / 178 |
| thymus | 59% | 19.86 | 383 / 653 | 26% | 0.43 | 159 / 605 |
| stomach | 46% | 16.35 | 166 / 359 | 32% | 0.59 | 91 / 286 |
| blood vessel | 77% | 46.04 | 1026 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 55% | 18.61 | 797 / 1445 | 17% | 0.31 | 31 / 183 |
| uterus | 44% | 15.77 | 74 / 170 | 19% | 0.35 | 88 / 459 |
| liver | 34% | 13.37 | 76 / 226 | 26% | 0.87 | 106 / 406 |
| skin | 18% | 4.89 | 320 / 1809 | 39% | 0.87 | 182 / 472 |
| heart | 42% | 14.87 | 360 / 861 | 0% | 0 | 0 / 0 |
| ovary | 21% | 6.84 | 38 / 180 | 16% | 0.29 | 68 / 430 |
| brain | 10% | 3.92 | 266 / 2642 | 18% | 0.35 | 129 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 0.27 | 9 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.35 | 5 / 29 |
| muscle | 5% | 0.99 | 39 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002376 | Biological process | immune system process |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004888 | Molecular function | transmembrane signaling receptor activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CD300LB |
| Protein name | CMRF35-like molecule 7 (CLM-7) (CD300 antigen-like family member B) (CMRF35-A2) (Immune receptor expressed on myeloid cells 3) (IREM-3) (Leukocyte mono-Ig-like receptor 5) (Triggering receptor expressed on myeloid cells 5) (TREM-5) (CD antigen CD300b) CD300 molecule like family member b |
| Synonyms | CLM7 CMRF35A2 IREM3 TREM5 LMIR5 CD300B UNQ2530/PRO6029 |
| Description | FUNCTION: Acts as an activating immune receptor through its interaction with ITAM-bearing adapter TYROBP, and also independently by recruitment of GRB2. . |
| Accessions | A8K4G0 ENST00000314401.3 ENST00000392621.6 J9JID3 ENST00000709208.1 |
